BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 32962752)

  • 1. Consensus Recommendations on the Use of
    Chen DL; Ballout S; Chen L; Cheriyan J; Choudhury G; Denis-Bacelar AM; Emond E; Erlandsson K; Fisk M; Fraioli F; Groves AM; Gunn RN; Hatazawa J; Holman BF; Hutton BF; Iida H; Lee S; MacNee W; Matsunaga K; Mohan D; Parr D; Rashidnasab A; Rizzo G; Subramanian D; Tal-Singer R; Thielemans K; Tregay N; van Beek EJR; Vass L; Vidal Melo MF; Wellen JW; Wilkinson I; Wilson FJ; Winkler T
    J Nucl Med; 2020 Dec; 61(12):1701-1707. PubMed ID: 32948678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Positron Emission Tomography/Computed Tomography in Gastrointestinal Malignancies: A Brief Review and Pictorial Essay.
    Sharma A; Ravindra SG; Singh TP; Kumar R
    Indian J Nucl Med; 2022; 37(3):249-258. PubMed ID: 36686294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic brain imaging with glucosamine CEST MRI: in vivo characterization and first insights.
    Rivlin M; Perlman O; Navon G
    Sci Rep; 2023 Dec; 13(1):22030. PubMed ID: 38086821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of butylscopolamine on [
    Gühne F; Ndum F; Seifert P; Winkens T; Drescher R; Freesmeyer M
    EJNMMI Res; 2023 Jun; 13(1):61. PubMed ID: 37340145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of the Random Forest Model via Combining CT-PET Image Features and Demographic Data for Distant Metastases among Lung Cancer Patients.
    Bi L; Guo Y
    J Healthc Eng; 2022; 2022():7793533. PubMed ID: 36561373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM).
    Totzeck M; Aide N; Bauersachs J; Bucerius J; Georgoulias P; Herrmann K; Hyafil F; Kunikowska J; Lubberink M; Nappi C; Rassaf T; Saraste A; Sciagra R; Slart RHJA; Verberne H; Rischpler C
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):792-812. PubMed ID: 36334105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer.
    Lo YL; Wang TY; Chen CJ; Chang YH; Lin AM
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.
    Kersting D; Settelmeier S; Mavroeidi IA; Herrmann K; Seifert R; Rischpler C
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT variants and pitfalls in malignant melanoma.
    Aide N; Iravani A; Prigent K; Kottler D; Alipour R; Hicks RJ
    Cancer Imaging; 2022 Jan; 22(1):3. PubMed ID: 34983677
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of metformin on
    Zhang X; Ogihara T; Zhu M; Gantumur D; Li Y; Mizoi K; Kamioka H; Tsushima Y
    Br J Radiol; 2022 Feb; 95(1130):20200810. PubMed ID: 34705528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Caresia-Aróztegui AP; Delgado-Bolton RC; Alvarez-Ruiz S; Del Puig Cózar-Santiago M; Orcajo-Rincon J; de Arcocha-Torres M; García-Velloso MJ;
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):59-68. PubMed ID: 30429069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
    Kitajima K; Miyoshi Y
    Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT.
    Dudoignon D; Pattison DA; Legallois D; Hicks RJ; Aide N
    Cancer Imaging; 2020 Sep; 20(1):68. PubMed ID: 32962752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Diagnostic Performance of
    Swart LE; Gomes A; Scholtens AM; Sinha B; Tanis W; Lam MGEH; van der Vlugt MJ; Streukens SAF; Aarntzen EHJG; Bucerius J; van Assen S; Bleeker-Rovers CP; van Geel PP; Krestin GP; van Melle JP; Roos-Hesselink JW; Slart RHJA; Glaudemans AWJM; Budde RPJ
    Circulation; 2018 Oct; 138(14):1412-1427. PubMed ID: 30018167
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.